Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Antithrombin Market: By Source, By Application, By Dosage Form, By End User, and Geography
Antithrombin Market: By Source, By Application, By Dosage Form, By End User, and Geography
Antithrombin Market size was valued at US$ 510.13 million in 2023, growing at a CAGR of 5.2% from 2023-2029. Antithrombin is protein molecule which inactivates various enzymes of coagulation system. It is produced by liver, consists of 432 amino acids. It consists of three disulphide bonds and four glycosylation sites. ?-Antithrombin is most common antithrombin form found in blood plasma. Antithrombin shows synergistic activity with heparin, that enhances the antithrombin binding with Thrombin (factor II a) and Factor Xa. Wide range of antithrombin applications for various medical conditions like disseminated intravascular coagulation, hereditary antithrombin deficiency, extracorporeal membrane oxygenation, and increased clinical significance of engineered antithrombin in the prevention of late peripartum and perioperative blood clots are expected to drive the revenue There growth of antithrombin market across the globe. Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, Furthermore, increase in prevalence of blood clotting-related disorders and, the growing geriatric population is expected to propel the antithrombin market. However, the high cost of antithrombin products, lack of awareness, and risks related with blood and blood-related products expected to dampen the growth of Antithrombin market. In April 2014, Revo Biologics started preserve 1 phase III clinical trials of ATryn (recombinant antithrombin) for the treatment of preeclampsia in pregnant women during the 24th to 28th weeks of pregnancy.
Study Period
2024-2030Base Year
2023CAGR
5.2%Largest Market
North AmericaFastest Growing Market
Europe
Rise in usage of heparin and antithrombin combination is the major driving factor for the growth of antithrombin market. For example, heparin resistance cardiac surgery is providing many opportunities for use of antithrombin product in anticoagulation therapy. Antithrobin market is highly consolidated owing to the presence of well-established players. The market is dominated by few players with large economic share. Market players focused on many growth strategies like mergers and acquisitions, new product launches to increase the product portfolio, to strengthen geographical presence.
Geographically antithrombin market is segmented as Latin America, Europe, Asia Pacific, North America, and The Middle East and Africa. North America is leading market in global antithrombin market followed by Europe. U.S. expected account for major revenue share in North America antithrombin market owing to technological advancements, increase in prevalence of blood clotting disorders, well established healthcare infrastructure. In Europe, Germany, UK and France are leading countries in antithrombin market due to favourable insurance coverages, increase in government initiatives, presence of well-established players. Asia Pacific antithrombin market is expected to offer enormous growth opportunities due to increase investments by global players, rise in disposable incomes, increasing awareness regarding blood clotting disorders, initiatives taken by governments.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 510.13 million |
|
Market CAGR |
5.2% |
|
By Source |
|
|
By Application |
|
|
By Dosage Form |
|
|
By End User |
|
Download Free Sample Report
The antithrombin market size was valued at US$ 510.13 million in 2022
The antithrombin market key players are: Grifols (Spain) rEVO Biologics, Inc. (U.S.) Kedrion S.p.A (Italy) CSL Limited (Australia) Scripps Laboratories, Inc. (U.S.) Lee Bisolutions, Inc. (U.S.) Dem ilac, Inc. (U.S.) Diapharma Group, Inc.(U.S.) Octapharma AG (Switzerland)
The antithrombin market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Antithrombin Market Introduction |
| 2.1.Global Antithrombin Market - Taxonomy |
| 2.2.Global Antithrombin Market - Definitions |
| 2.2.1.Source |
| 2.2.2.Application |
| 2.2.3.Dosage Form |
| 2.2.4.End User |
| 2.2.5.Region |
| 3. Global Antithrombin Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Antithrombin Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Antithrombin Market By Source, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Goat Milk |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Human |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Others |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Antithrombin Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Diagnostics |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Therapeutics |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Research |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Antithrombin Market By Dosage Form, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Liquid |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Lyophilized |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Antithrombin Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Blood Banks |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Diagnostic Centres |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Hospitals |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Antithrombin Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Antithrombin Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Source Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Goat Milk |
| 10.1.2.Human |
| 10.1.3.Others |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Diagnostics |
| 10.2.2.Therapeutics |
| 10.2.3.Research |
| 10.3. Dosage Form Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Liquid |
| 10.3.2.Lyophilized |
| 10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Blood Banks |
| 10.4.2.Diagnostic Centres |
| 10.4.3.Hospitals |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Antithrombin Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Source Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Goat Milk |
| 11.1.2.Human |
| 11.1.3.Others |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Diagnostics |
| 11.2.2.Therapeutics |
| 11.2.3.Research |
| 11.3. Dosage Form Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Liquid |
| 11.3.2.Lyophilized |
| 11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Blood Banks |
| 11.4.2.Diagnostic Centres |
| 11.4.3.Hospitals |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Antithrombin Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Source Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Goat Milk |
| 12.1.2.Human |
| 12.1.3.Others |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Diagnostics |
| 12.2.2.Therapeutics |
| 12.2.3.Research |
| 12.3. Dosage Form Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Liquid |
| 12.3.2.Lyophilized |
| 12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Blood Banks |
| 12.4.2.Diagnostic Centres |
| 12.4.3.Hospitals |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Antithrombin Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Source Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Goat Milk |
| 13.1.2.Human |
| 13.1.3.Others |
| 13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Diagnostics |
| 13.2.2.Therapeutics |
| 13.2.3.Research |
| 13.3. Dosage Form Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Liquid |
| 13.3.2.Lyophilized |
| 13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Blood Banks |
| 13.4.2.Diagnostic Centres |
| 13.4.3.Hospitals |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Antithrombin Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Source Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Goat Milk |
| 14.1.2.Human |
| 14.1.3.Others |
| 14.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Diagnostics |
| 14.2.2.Therapeutics |
| 14.2.3.Research |
| 14.3. Dosage Form Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Liquid |
| 14.3.2.Lyophilized |
| 14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Blood Banks |
| 14.4.2.Diagnostic Centres |
| 14.4.3.Hospitals |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Grifols (Spain) |
| 15.2.2.rEVO Biologics, Inc. (U.S.) |
| 15.2.3.Kedrion S.p.A (Italy) |
| 15.2.4.CSL Limited (Australia) |
| 15.2.5.Scripps Laboratories, Inc. (U.S.) |
| 15.2.6.Lee Bisolutions, Inc. (U.S.) |
| 15.2.7.Dem ilac, Inc. (U.S.) |
| 15.2.8.Diapharma Group, Inc.(U.S.) |
| 15.2.9.Octapharma AG (Switzerland) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.